Mobile site search icon.
Mobile navigation icon.

TAKHZYRO (lanadelumab-flyo) is indicated for prophylaxis to prevent attacks of hereditary angioedema (HAE) in patients ≥2 years of age.

TAKHZYRO (lanadelumab-flyo) is indicated for prophylaxis to prevent attacks of hereditary angioedema (HAE) in patients ≥2 years of age.

FIND AN HAE EVENT

Educational events can help keep you informed about the most recent updates in the HAE community. You can hear from HAE experts as well as real patients taking TAKHZYRO. Find out if an in-person event is happening near you, or search for a virtual event.

Your patients can find events as well by visiting TAKHZYRO + You.

Filter

Enter your ZIP code and preferred location below to find an event near you.

Please enter a valid ZIP code.
Distance
  • 10 mi
  • 25 mi
  • 50 mi
  • 100 mi
Language
  • English
  • Spanish
  • All